EEDQ

Overview

EEDQ is a carboxylate activator and irreversible antagonist of 5HT2c receptors. EEDQ reduces [ 3 H]β-CIT binding to the dopamine transporter ( DAT ) in rat caudate-putamen (CPu) homogenates ( IC 50 = 78.3 μM). EEDQ inhibits contralateral rotation behavior.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Biochemical Assay Reagents | Products > Signaling Pathways > 5-HT Receptor | Products > Signaling Pathways > Dopamine Transporter

Product Information

• Catalog No.: HY-Y1191
• CAS No.: 16357-59-8
• Molecular Formula: C14H17NO3
• Molecular Weight: 247.29
• Purity: 99.97%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 5 mg/mL (20.22 mM); Clear solution
• Availability: In-stock

Source

Original product source